In AD, extracellular deposition of the ∼4 kDa amyloid-β (Aβ) peptide derived from the amyloid precursor protein (APP), leads to amyloid plaques and neurotoxic oligomers that impair long term potentiation (LTP) and synaptic function [1]. Here, APP is linked to amyloidosis.